Solid Biosciences Inc.
SLDB· Nasdaq
Released Nov 3, 2025, after the close
10-Q filed Nov 3, 2025, 34 days after period end · 0001193125-25-262818
| Metric | Q3 2025 | Q3 2024 | Q3 2023 | Q3 2022 |
|---|---|---|---|---|
| Net Income | -$45.78M | -$32.73M | -$20.98M | -$20.41M |
| EPS Diluted | -$0.48 | -$0.79 | -$1.05 | -$2.71 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Solid Biosciences Inc. · CIK 1707502 · Engraved from SEC EDGAR